Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature

PLoS Negl Trop Dis. 2021 Mar 25;15(3):e0009191. doi: 10.1371/journal.pntd.0009191. eCollection 2021 Mar.

Abstract

Background: Hepatosplenic schistosomiasis (HSS) is a disease caused by chronic infection with Schistosma spp. parasites residing in the mesenteric plexus; portal hypertension causing gastrointestinal bleeding is the most dangerous complication of this condition. HSS requires complex clinical management, but no specific guidelines exist. We aimed to provide a comprehensive picture of consolidated findings and knowledge gaps on the diagnosis and treatment of HSS.

Methodology/principal findings: We reviewed relevant original publications including patients with HSS with no coinfections, published in the past 40 years, identified through MEDLINE and EMBASE databases. Treatment with praziquantel and HSS-associated pulmonary hypertension were not investigated. Of the included 60 publications, 13 focused on diagnostic aspects, 45 on therapeutic aspects, and 2 on both aspects. Results were summarized using effect direction plots. The most common diagnostic approaches to stratify patients based on the risk of variceal bleeding included the use of ultrasonography and platelet counts; on the contrary, evaluation and use of noninvasive tools to guide the choice of therapeutic interventions are lacking. Publications on therapeutic aspects included treatment with beta-blockers, local management of esophageal varices, surgical procedures, and transjugular intrahepatic portosystemic shunt. Overall, treatment approaches and measured outcomes were heterogeneous, and data on interventions for primary prevention of gastrointestinal bleeding and on the long-term follow-up after interventions were lacking.

Conclusions: Most interventions have been developed on the basis of individual groups' experiences and almost never rigorously compared; furthermore, there is a lack of data regarding which parameters can guide the choice of intervention. These results highlight a dramatic need for the implementation of rigorous prospective studies with long-term follow-up in different settings to fill such fundamental gaps, still present for a disease affecting millions of patients worldwide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Liver Diseases, Parasitic / diagnosis*
  • Liver Diseases, Parasitic / therapy*
  • Schistosomiasis / diagnosis*
  • Schistosomiasis / therapy*
  • Splenic Diseases / diagnosis*
  • Splenic Diseases / parasitology*
  • Splenic Diseases / therapy*

Grants and funding

This work was supported by the Italian Ministry of Health "Fondi Ricerca Corrente - L3P1" to IRCCS Sacro Cuore Don Calabria Hospital, Negrar, Verona, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.